Cutaneous Collagenous Vasculopathy Associated With Antibody-Drug Conjugate Treatment

This case report describes cutaneous collagenous vasculopathy associated with loncastuximab tesirine, an antibody-drug conjugate treatment.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2024-08-21
DOI
https://doi.org/10.1001/jamadermatol.2024.2324
Citations
5
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
1.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cutaneous Collagenous Vasculopathy Associated With Antibody-Drug Conjugate Treatment

Andrea Michelerio, Francesco Cabutti, Carlo Tomasini
5 citations
JAMA Dermatology
HER2/EGFR in Cancer Research
1.41
article

Cutaneous Collagenous Vasculopathy Associated With Antibody-Drug Conjugate Treatment

Andrea Michelerio, Francesco Cabutti, Carlo Tomasini
article en
5 citations

Abstract

This case report describes cutaneous collagenous vasculopathy associated with loncastuximab tesirine, an antibody-drug conjugate treatment.

JAMA DermatologyVol. 160(10)
University of Pavia (IT), Azienda Sanitaria Locale di Asti (IT), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Good health and well-being
Openalex Percentile: Top 16%
HER2/EGFR in Cancer Research
1.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cutaneous Collagenous Vasculopathy Associated With Antibody-Drug Conjugate Treatment — Andrea Michelerio, Francesco Cabutti, et al. · JAMA Dermatology (2024) | TGRS Research Map | TGRS